The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid (Q46178460)

20 December 2017

title

The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid (English)

1 reference

20 December 2017

Lalowski M

1 reference

20 December 2017

author name string

Golabek A

1 reference

20 December 2017

Lemere CA

1 reference

20 December 2017

Selkoe DJ

1 reference

20 December 2017

Wisniewski HM

1 reference

20 December 2017

Beavis RC

1 reference

20 December 2017

Frangione B

1 reference

20 December 2017

Wisniewski T

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 December 1996

1 reference

20 December 2017

Journal of Biological Chemistry

published in

1 reference

20 December 2017

volume

271

1 reference

20 December 2017

issue

1 reference

20 December 2017

page(s)

33623-33631

1 reference

20 December 2017

Alzheimer's disease and soluble A beta

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Ultrastructural localization of argyrophilic substances in diffuse plaques of Alzheimer-type dementia demonstrated by methenamine silver staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Review. David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Amyloid beta protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Differences between vascular and plaque core amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Amyloid beta 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Early amyloid-beta deposits show different immunoreactivity to the amino- and carboxy-terminal regions of beta-peptide in Alzheimer's disease and Down's syndrome brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Increasing the dynamic range of a transient recorder by using two analog-to-digital converters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Structural characterization of protein tryptic peptides via liquid chromatography/mass spectrometry and collision-induced dissociation of their doubly charged molecular ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Influence of matrix solution conditions on the MALDI-MS analysis of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Evidence that Aβ42 is the real culprit in alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Characterization of beta-amyloid peptide from human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Rolling-circle replication of a high-copy BPV-1 plasmid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid beta/A4 peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Parenchymal preamyloid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis--Dutch type

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Mechanisms of neuronal degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Is Alzheimer's disease an apolipoprotein E amyloidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

S182 protein in Alzheimer's disease neuritic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.52.33623

21 January 2018

Identifiers

DOI

10.1074/JBC.271.52.33623

1 reference

20 December 2017

1 reference

20 December 2017